Photonics in the development of personalized medicine

Photonik in der Entwicklung der personalisierten Medizin
Personalized medicine refers to the concept that detection and treatment of disease can be tailored to match the characteristics of the individual patient and their particular pathology, moving away from the "one size fits all" traditional approach [1] [2] [3] [4] [5] . This is made possible by the huge growth in "-omics" knowledge (genomics, proteomics, metabolomics, etc.) that identifies specific biomarkers of disease and by corresponding technological capabilities to utilize this knowledge for diagnostics (e.g., imaging) and targeted interventions [5] [6] [7] . Hence, each field of biomedical technology is examining how it can contribute to this revolution, and photonics is no exception as exemplified by the papers in this special issue of Photonics & Lasers in Medicine. This is also evident in the recent increase of particular in-vivo molecular imaging-related studies to detect disease [8] or monitor therapy [9, 10] .
Thus, in this issue MacDonald and Zheng [11] in Toronto, Canada summarize the status and potential of novel all-organic nanoparticles with multi-modal capabilities for optical imaging (fluorescence, photoacoustic), complementary non-optical imaging (positron emission tomography, magnetic resonance imaging) and lightbased therapies (photodynamic, photothermal). The personalized aspect comes here through the targeting of the nanoparticles using known biomarkers to limit the therapeutic dose exclusively to that targeted tissue volume.
Laura Kerr and colleagues [12] in Ireland describe the use of Raman spectroscopy and spectral mapping as intrinsic tissue biomarkers, as applied to the challenge of bladder cancer detection. The goal is real-time classification of tissue at different stages of transformation, so that localized surgical removal or in situ ablation is enabled only at the locations with high sensitivity and specificity towards the diseased tissue. Also utilizing intrinsic optical signals, Scolaro et al. [13] in Australia review the use of optical coherence tomography (OCT) in breast cancer and in particular show the potential of OCT elastography for detecting cancer margins during lumpectomy. This concept of active optical guidance in cancer surgery is a significant emerging trend that offers the potential to reduce the risk of tumor progression and the need for second surgery, and is being pursued by many groups using different light-tissue interactions. Optical guidance for treatment intervention is also the topic of the work of He et al. [14] in Canada, who describe the use of diffuse optical tomography to monitor in near real time the growth of the coagulation zone in photothermal destruction of localized prostate cancer. This, as an alternative to thermal mapping by magnetic resonance imaging, promises higher accuracy, lower cost and more accessibility. Overall, these different optical techniques can provide a significant increase in patient safety through the elimination of unnecessary removal of or damage to normal tissue while retaining the highest therapeutic response rates.
Still on the therapeutic theme, Anderson Amaro dos Santos and colleagues [15] in Saõ Paulo, Brazil present preclinical results using low-intensity photostimulation to accelerate cartilage repair in osteoarthritis. This utilizes the intrinsic signaling pathways of cells to induce the desired biological effects exclusively to the cartilage. By contrast, Gaitanis and coworkers [16] in Greece present a case report of the use of a high power-pumped dye laser and an applied exogenous agent to treat localized skin cancer as an alternative to surgery, with excellent cosmetic outcome, showing the capability of optical techniques to increase the "therapeutic window" to achieve an improved risk-benefit ratio in individual patients.
For therapeutic guidance, Qiu et al. [17] in Fuzhou, China demonstrate the clinical use of diffuse reflectance spectroscopy to monitor the effectiveness of vascular-targeted photodynamic therapy on port-wine stains, which is critical to obtain the best cosmetic outcome in these highly heterogeneous disfiguring lesions. In particular, the distribution of vessel diameter as function of depth below the surface needs to be considered when determining the required photodynamic dose to achieve the best therapeutic outcome.
The papers in this special issue illustrate well the breadth of opportunities for photonics to contribute to the evolution of personalized medicine. However, they represent only the tip of the iceberg in exploiting the unique advantages of biophotonics in addressing the needs and opportunities of personalized medicine: molecular sensitivity, low risk, minimal invasiveness, low cost and ease of integration with other clinical technologies including existing clinical imaging modalities. We can expect significant synergetic effects between photonics and the life sciences and their translation into new personalized techniques in the upcoming "International Year of Light 2015" [18] [19] [20] , and the decade beyond.
